Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	110.78	70.32	-33.36
Graham Fair Price	-35.07	42720.77	65796.97
PEG	177146.81	-0.02	< 0.005
Price/Book	1.82	0.30	0.29
Price/Cash Flow	-124.81	-11.88	-5.28
Prices/Earnings	143.53	2.37	-0.97
Price/Sales	10.58	0.42	0.38
Price/FCF	-124.81	-11.88	-5.28
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	319.25	0.09	-0.02
Operating Margin	-60.30	0.02	-0.06
ROA	-58.55	< 0.005	-0.02
ROE	-0.07	0.03	-58.19
ROIC	-0.02	< 0.005	-69.36
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.06	-0.03	91.09
Dividends QOQ	-0.59	-1.00	-70.60
EBIT QOQ	-4.20	1.37	-67.44
EPS QOQ	-1041.05	1.43	-99.86
FCF QOQ	-48.89	0.55	-98.88
Revenue QOQ	0.07	-0.08	9.57
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	35.54	42.09	18.42
Days Sales Outstanding (DSO)	132.80	131.02	-1.34
Inventory Turnover	2.53	2.14	-15.56
Debt/Capitalization	0.55	0.57	2.45
Quick Ratio	0.88	0.86	-1.40
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	50824.77	51034.41	0.41
Cash	32968.78	34306.41	4.06
Capex	-2002.99	-1469.75	26.62
Free Cash Flow	-2787.88	-1267.86	54.52
Revenue	39126.79	36175.69	-7.54
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.08	1.09	0.68
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-24.49	52.22	113.23
Naive Interpretation	Member

06 - Financial Health · Bad

Rating